Results 11 to 20 of about 662,017 (326)

Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure

open access: yesJournal of Clinical Medicine, 2021
Background: As of 8 April 2021, a total of 2.9 million people have died with or from the coronavirus infection causing COVID-19 (Corona Virus Disease 2019).
M. Wolf   +5 more
semanticscholar   +1 more source

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases

open access: yesBrain, behavior, and immunity, 2021
Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine.
Puja R. Mehta   +6 more
semanticscholar   +1 more source

Successful treatment of cerebral venous sinus thrombosis by balloon venoplasty: a case report

open access: yesJournal of International Medical Research, 2021
Cerebral venous sinus thrombosis is a special cerebrovascular disease affecting young adult and middle-aged people. The clinical manifestations of cerebral venous sinus thrombosis are diverse and nonspecific; thus, imaging plays an important role in ...
Wei Chen   +5 more
doaj   +1 more source

Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature

open access: yesJournal of Stroke & Cerebrovascular Diseases, 2021
Background COVID-19 infection has been known to predispose patients to both arterial and venous thromboembolic events such as deep venous thrombosis, pulmonary embolism, myocardial infarction, and stroke.
M. Abdalkader   +18 more
semanticscholar   +1 more source

Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency

open access: yesEuropean Journal of Neurology, 2021
Cerebral venous sinus thrombosis (CVST) has been described after vaccination against SARS‐CoV‐2. The clinical characteristics of 213 post‐vaccination CVST cases notified to the European Medicines Agency are reported.
K. Krzywicka   +16 more
semanticscholar   +1 more source

Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Population‐based data about cerebral venous sinus thrombosis (CVST) are limited.
Amanda B. Payne   +6 more
semanticscholar   +1 more source

Hypodense cerebral venous sinus thrombosis on unenhanced CT: A potential pitfall. Report of a case and review of the literature

open access: yesRadiology Case Reports, 2020
Cerebral venous sinus thrombosis is an uncommon disorder that requires prompt diagnosis and treatment to prevent serious complications. Due to the broad spectrum of clinical presentations, patients typically undergo noncontrast CT as the first imaging ...
Emily Neal, John Sturgeon, MD
doaj   +1 more source

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination

open access: yesEuropean Journal of Neurology, 2021
High mortality rates have been reported in patients with cerebral venous sinus thrombosis (CVST) due to vaccine‐induced immune thrombotic thrombocytopenia (VITT) after vaccination with adenoviral vector SARS‐CoV‐2 vaccines.
Anita van de Munckhof   +14 more
semanticscholar   +1 more source

Idiopathic Cavernous Sinus Thrombosis Presenting Unilateral Abducens Nerve Palsy [PDF]

open access: yesJournal of Neurocritical Care, 2014
Background: Cavernous sinus thrombosis is usually caused by infection, such as sinusitis and dental or facial infections. Idiopathic cavernous sinus thrombosis is very rare.
Cheolsoo Han   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy